Evidence map›Paper›PMID 38076026›Full record

ArticleIJID regions2024

Pattern of cephalosporin and carbapenem-resistant

Salma AlBahrani, Thikrayat Qazih Alqazih, Ali Ahmad Aseeri, Reem Al Argan, Dania Alkhafaji, Nora Abdullah Alrqyai, Sami Mohamed Alanazi, Dima Saleh Aldakheel, Qassim Hassan Ghazwani, Salah Saeed Jalalah and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Salma AlBahraniInfectious Disease Unit, Specialty Internal Medicine, King Fahd Military Medical Complex, Dhahran, College of medicine-Imam Abdulrahaman Bin Faisal University, Dammam, Saudi Arabia.
Thikrayat Qazih AlqazihMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Ali Ahmad AseeriMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Reem Al ArganDepartment of Internal Medicine, College of Medicine, Imam Abdulrhaman Bin Faisal University, King Fahd Hospital of the University, Khobar, Saudi Arabia.
Dania AlkhafajiDepartment of Internal Medicine, College of Medicine, Imam Abdulrhaman Bin Faisal University, King Fahd Hospital of the University, Khobar, Saudi Arabia.
Nora Abdullah AlrqyaiMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Sami Mohamed AlanaziMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Dima Saleh AldakheelMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Qassim Hassan GhazwaniMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Salah Saeed JalalahMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Anwar Khalid AlshuaibiMicrobiology Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Hanadi Ali HazzaziInfection control Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.
Jaffar A Al-TawfiqInfectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Despite its financial cost on the world's health care system, Methods: This retrospective analysis covered the period from January 2019 to December 2022 and included cephalosporin- and carbapenem-resistant Results: During the time of the study, 1815 clinical isolates of Conclusion: This study emphasizes the alarming patterns of carbapenem and cephalosporin resistance among

Indexed as

carbapenemaseColistinCREMDRPseudomonas aeruginosa

Identifiers

PMID38076026
PMCPMC10701576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.